Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Jon C. Ogg | Nov 13, 2013 at 3:57 PM EST

New Healthcare Enrollment Numbers Continue To Amaze

Healthcare.govThe Affordable Care Act is becoming more and more of a misnomer each day, and its broad appeal is running…

Jon C. Ogg | Nov 12, 2013 at 10:05 AM EST

Dendreon Restructuring Aims to Thwart Weak Provenge Sales

ThinkstockDendreon Corp. (NASDAQ: DNDN) has been down and out, and now the company is going to try a restructuring strategy…

Trey Thoelcke | Nov 11, 2013 at 7:30 AM EST

Shire, Novartis Deals: Pharmaceutical Shakeups Continue

ThinkstockThe wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ:…

Jon C. Ogg | Nov 7, 2013 at 3:52 PM EST

Geron Move Seems Hard To Interpret As Sustainable

ThinkstockSeeing Geron Corporation (NASDAQ: GERN) as one of the top gaining stories on the day brought back memories of when…

Lee Jackson | Nov 7, 2013 at 8:45 AM EST

J.P. Morgan Offers Stocks to Buy as Winners of the Obamacare Debacle

ThinkstockThe administration has basically admitted that the rollout and launch of the Affordable Care Act, or Obamacare, has been nothing…

Trey Thoelcke | Nov 7, 2013 at 7:10 AM EST

Nestle Dumps Jenny Craig

ThinkstockAs part of it ongoing efforts to trim down by shedding weaker brands, Swiss food giant Nestle has announced that…

Jon C. Ogg | Nov 5, 2013 at 1:10 PM EST

Four Big Healthy Biotech Gainers, One Big Loser

ThinkstockBiotech and certain aspects of the health care and life sciences sector can often see incredible surges from day to…

Jon C. Ogg | Nov 4, 2013 at 1:59 PM EST

Does the $2 Billion Settlement Jeopardize Dividends at J&J?

Wikimedia CommonsJohnson & Johnson (NYSE: JNJ) is facing a serious settlement charge-off that is somehow a victory for shareholders. J&J…

Jon C. Ogg | Nov 2, 2013 at 7:15 AM EDT

Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex

ThinkstockIdenix Pharmaceuticals Inc. (NASDAQ: IDIX) was the biggest gainer of all listed stocks on Friday with a rally of 40%.…

Jon C. Ogg | Oct 31, 2013 at 9:55 AM EDT

Ariad Going to Hell in a Handbasket

ThinkstockThings just keep getting worse for Ariad Pharmaceuticals Inc. (NASDAQ: ARIA). In fact, a series of shareholder revolts are probably…

Trey Thoelcke | Oct 30, 2013 at 7:10 AM EDT

Teva Pharmaceutical Shares Plunge on CEO Resignation

ThinkstockAfter denying rumors earlier this week that its CEO was considering resigning, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced Wednesday…

Paul Ausick | Oct 29, 2013 at 8:00 AM EDT

Pfizer Continues to Shrink

Wikimedia CommonsPfizer Inc. (NYSE: PFE) reported third-quarter 2013 results before markets opened Tuesday morning. The drug maker posted adjusted diluted…

Jon C. Ogg | Oct 28, 2013 at 1:19 PM EDT

Merck Sets Low Earnings Bar for Pfizer

The drug patent cliff for Big Pharma is coming with some continued consequences, and two drug giants with earnings this…

Jon C. Ogg | Oct 28, 2013 at 11:25 AM EDT

Four Companies That Easily Could Run the Healthcare.gov Sign-Up Process

Healthcare.govSince the passage of the Affordable Care Act, or Obamacare, the launch has been riddled with problems. Accessing the sign-up…

Paul Ausick | Oct 28, 2013 at 7:50 AM EDT

Merck Continues to Face Revenue Challenges

ThinkstockDrug giant Merck & Co. Inc. (NYSE: MRK) reported third-quarter 2013 results before markets opened Monday morning. The company posted…

1 … 297 298 299 300 301 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

New Healthcare Enrollment Numbers Continue To Amaze

Dendreon Restructuring Aims to Thwart Weak Provenge Sales

Shire, Novartis Deals: Pharmaceutical Shakeups Continue

Geron Move Seems Hard To Interpret As Sustainable

J.P. Morgan Offers Stocks to Buy as Winners of the Obamacare Debacle

Nestle Dumps Jenny Craig

Four Big Healthy Biotech Gainers, One Big Loser

Does the $2 Billion Settlement Jeopardize Dividends at J&J?

Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex

Ariad Going to Hell in a Handbasket

Teva Pharmaceutical Shares Plunge on CEO Resignation

Pfizer Continues to Shrink

Merck Sets Low Earnings Bar for Pfizer

Four Companies That Easily Could Run the Healthcare.gov Sign-Up Process

Merck Continues to Face Revenue Challenges

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge

May CPI Surges to 4.2%, but the Fed May Not Be Ready to Raise Rates

Forget Intel Corporation: As June Volatility Rocks Chip Stocks, This Tech Monopoly Is The Smart Money Pivot

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge

Can You Afford To Retire To Trump Tower? We Ran the Budget. It's a Lot.

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge

May CPI Surges to 4.2%, but the Fed May Not Be Ready to Raise Rates

Health and Healthcare Articles

All Health and Healthcare Articles

New Healthcare Enrollment Numbers Continue To Amaze

Dendreon Restructuring Aims to Thwart Weak Provenge Sales

Shire, Novartis Deals: Pharmaceutical Shakeups Continue

Geron Move Seems Hard To Interpret As Sustainable

J.P. Morgan Offers Stocks to Buy as Winners of the Obamacare Debacle

Nestle Dumps Jenny Craig

Four Big Healthy Biotech Gainers, One Big Loser

Does the $2 Billion Settlement Jeopardize Dividends at J&J?

Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex

Ariad Going to Hell in a Handbasket

Teva Pharmaceutical Shares Plunge on CEO Resignation

Pfizer Continues to Shrink

Merck Sets Low Earnings Bar for Pfizer

Four Companies That Easily Could Run the Healthcare.gov Sign-Up Process

Merck Continues to Face Revenue Challenges

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge

May CPI Surges to 4.2%, but the Fed May Not Be Ready to Raise Rates

Forget Intel Corporation: As June Volatility Rocks Chip Stocks, This Tech Monopoly Is The Smart Money Pivot

Featured Reads

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge

Can You Afford To Retire To Trump Tower? We Ran the Budget. It's a Lot.